In other biopharma financing news this week, there were sizeable rounds for Noema Pharma, Angitia Biopharma, Citryll, and Veradermics. First up, Swiss start-up Noema Pharma has raised CHF 130 ...
At the moment, attention is focused on candidates like Emalex Biosciences' ecopipam and Noema Pharma's gemlapodect, both in midstage clinical testing. An extraordinary meeting of shareholders is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback